Introduction: Systemic lupus erythematosus (SLE) is a chronic autoimmune disease
characterized by organ damage, flare-remission pattern, and increased mortality when …

Both systemic lupus erythematosus (SLE) and its treatments can contribute to increased
mortality rates. The focus of this review is recent studies on mortality and comorbidities …

Glomerular disease, be it primary or secondary, occurring in the setting of systemic
autoimmune diseases, infections, drugs, or malignancy, affects individuals of all ages. In …

Infection is one of the major causes of mortality in patients with systemic lupus
erythematosus (SLE). We previously found that CD38, an ectoenzyme that regulates the …

Objectives Successful vaccination is key to overcoming the COVID-19 pandemic.
Immunosuppressive medication is known to potentially compromise vaccination responses …

Objectives We conducted a systematic review and meta-analysis to determine the
magnitude of infection risk in patients with SLE and evaluate the effect of general and SLE …

Abstract The coronavirus disease 2019 (COVID-19) pandemic is concerning for patients with
neuroimmunological diseases who are receiving immunotherapy. Uncertainty remains …

Objectives To estimate the incidence of severe infection and investigate the associated
factors and clinical impact in a large systemic lupus erythematosus (SLE) retrospective …

The relationship between the complement system and autoimmunity appears paradoxical as
both the deficiency and the activation contribute to inducing autoimmune diseases. In these …

This article is published as part of a supplement sponsored by Kidney Disease: Improving
Global Outcomes (KDIGO). The opinions or views expressed in this supplement are those of …